Health and Family Welfare Minister JP Nadda today held a review meeting with the Health Ministers and senior officials of Rajasthan and Maharashtra to evaluate healthcare delivery mechanisms. The discussions centred on reinforcing public health infrastructure, improving patient-centric services, strengthening regulatory frameworks, and advancing the country’s commitment to eliminating tuberculosis as a public health challenge.

 

During the review, Mr Nadda underlined the critical role of a strong and vigilant drug regulatory system. He stressed that end-to-end oversight, from manufacturing to last-mile distribution, is indispensable to ensure quality, safety, and public confidence. He called for the adoption of best regulatory practices and emphasised that patient satisfaction, compliance, and regulatory supervision must be pursued as a sustained and continuous endeavour.

 

Reviewing the progress of the Free Drugs and Free Diagnostics Initiatives, the Health Minister urged both States to address supply-chain inefficiencies and close monitoring gaps.